196 related articles for article (PubMed ID: 21128988)
21. Do MDR1 and SLCO1B1 polymorphisms influence the therapeutic response to atorvastatin? A study on a cohort of Egyptian patients with hypercholesterolemia.
Shabana MF; Mishriki AA; Issac MS; Bakhoum SW
Mol Diagn Ther; 2013 Oct; 17(5):299-309. PubMed ID: 23677857
[TBL] [Abstract][Full Text] [Related]
22. Role of genetic variant A-204C of cholesterol 7alpha-hydroxylase (CYP7A1) in susceptibility to gallbladder cancer.
Srivastava A; Pandey SN; Choudhuri G; Mittal B
Mol Genet Metab; 2008 May; 94(1):83-9. PubMed ID: 18178499
[TBL] [Abstract][Full Text] [Related]
23. [Influence of CETP gene -629C/A polymorphism on the efficacy of atorvastatin treatment and clinical outcome].
Gao J; Cong HL; Mao YM; Liu Y; Zhang N; Chen Q; Liu T; Cui R
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2013 Oct; 30(5):553-8. PubMed ID: 24078569
[TBL] [Abstract][Full Text] [Related]
24. Polymorphisms in ABCG5 and ABCG8 transporters and plasma cholesterol levels.
Hubácek JA; Berge KE; Stefková J; Pitha J; Skodová Z; Lánská V; Poledne R
Physiol Res; 2004; 53(4):395-401. PubMed ID: 15311998
[TBL] [Abstract][Full Text] [Related]
25. ABCG5/8 variants are associated with susceptibility to coronary heart disease.
Wu G; Li GB; Yao M; Zhang DQ; Dai B; Ju CJ; Han M
Mol Med Rep; 2014 Jun; 9(6):2512-20. PubMed ID: 24691589
[TBL] [Abstract][Full Text] [Related]
26. (TTA)n polymorphism in 3-hydroxy-3-methylglutaryl-coenzyme A and response to atorvastatin in coronary artery disease patients.
Noriega V; Pennanen C; Sánchez MP; Chiong M; Llancaqueo M; Lavandero S; Prieto JC
Basic Clin Pharmacol Toxicol; 2009 Mar; 104(3):211-5. PubMed ID: 19067673
[TBL] [Abstract][Full Text] [Related]
27. Plasma cholesterol is hyperresponsive to statin in ABCG5/ABCG8 transgenic mice.
Tang W; Ma Y; Yu L
Hepatology; 2006 Nov; 44(5):1259-66. PubMed ID: 17058264
[TBL] [Abstract][Full Text] [Related]
28. Pharmacogenetic predictors of statin-mediated low-density lipoprotein cholesterol reduction and dose response.
Voora D; Shah SH; Reed CR; Zhai J; Crosslin DR; Messer C; Salisbury BA; Ginsburg GS
Circ Cardiovasc Genet; 2008 Dec; 1(2):100-6. PubMed ID: 20031551
[TBL] [Abstract][Full Text] [Related]
29. Relationship between the cholesterol ester transfer protein TaqIB polymorphism and the lipid-lowering effect of atorvastatin in patients with coronary atherosclerotic heart disease.
Li J; Zhang L; Xie NZ; Deng B; Lv LX; Zheng LQ
Genet Mol Res; 2014 Mar; 13(1):2140-8. PubMed ID: 24737438
[TBL] [Abstract][Full Text] [Related]
30. The effects of ABCG5/G8 polymorphisms on HDL-cholesterol concentrations depend on ABCA1 genetic variants in the Boston Puerto Rican Health Study.
Junyent M; Tucker KL; Smith CE; Lane JM; Mattei J; Lai CQ; Parnell LD; Ordovas JM
Nutr Metab Cardiovasc Dis; 2010 Oct; 20(8):558-66. PubMed ID: 19692220
[TBL] [Abstract][Full Text] [Related]
31. Cholesteryl ester transfer protein and ATP-binding cassette transporter A1 genotype alter the atorvastatin and simvastatin efficacy: time for genotype-guided therapy?
Kolovou G; Kolovou V; Mihas C; Giannakopoulou V; Vasiliadis I; Boussoula E; Kollia A; Boutsikou M; Katsiki N; Mavrogeni S
Angiology; 2013 May; 64(4):266-72. PubMed ID: 22584245
[TBL] [Abstract][Full Text] [Related]
32. Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response.
Cenarro A; Artieda M; Gonzalvo C; Meriño-Ibarra E; Arístegui R; Gañán A; Díaz C; Sol JM; Pocoví M; Civeira F;
Am Heart J; 2005 Dec; 150(6):1154-62. PubMed ID: 16338252
[TBL] [Abstract][Full Text] [Related]
33. Role of cholesterol 7alpha-hydroxylase (CYP7A1) in nutrigenetics and pharmacogenetics of cholesterol lowering.
Hubacek JA; Bobkova D
Mol Diagn Ther; 2006; 10(2):93-100. PubMed ID: 16669607
[TBL] [Abstract][Full Text] [Related]
34. Hepatic expression of ABC transporters G5 and G8 does not correlate with biliary cholesterol secretion in liver transplant patients.
Geuken E; Visser DS; Leuvenink HG; de Jong KP; Peeters PM; Slooff MJ; Kuipers F; Porte RJ
Hepatology; 2005 Nov; 42(5):1166-74. PubMed ID: 16250035
[TBL] [Abstract][Full Text] [Related]
35. [Cholesterol 7α-Hydroxylase Gene-204A/C Polymorphism in Normal and Gestational Diabetic Pregnancies].
Liu SX; Bai H; Guan LB; Liu XH; Fan P; Zhou M; Wu YJ; Tang FM; Wang YF; Li DH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 54(2):361-366. PubMed ID: 36949699
[TBL] [Abstract][Full Text] [Related]
36. The A-204C polymorphism in the cholesterol 7alpha-hydroxylase (CYP7A1) gene determines the cholesterolemia responsiveness to a high-fat diet.
Kovár J; Suchánek P; Hubácek JA; Poledne R
Physiol Res; 2004; 53(5):565-8. PubMed ID: 15479137
[TBL] [Abstract][Full Text] [Related]
37. Influence of
Mladenovska K; Grapci AD; Vavlukis M; Kapedanovska A; Eftimov A; Geshkovska NM; Nebija D; Dimovski AJ
Pharmazie; 2017 May; 72(5):288-295. PubMed ID: 29441875
[TBL] [Abstract][Full Text] [Related]
38. Association of selected ABC gene family single nucleotide polymorphisms with postprandial lipoproteins: results from the population-based Hortega study.
Abellán R; Mansego ML; Martínez-Hervás S; Martín-Escudero JC; Carmena R; Real JT; Redon J; Castrodeza-Sanz JJ; Chaves FJ
Atherosclerosis; 2010 Jul; 211(1):203-9. PubMed ID: 20170916
[TBL] [Abstract][Full Text] [Related]
39. The effect of leptin promoter and leptin receptor gene polymorphisms on lipid profile among the diabetic population: modulations by atorvastatin treatment and environmental factors.
Al-Azzam SI; Khabour OF; Alzoubi KH; Alzayadeen RN
J Endocrinol Invest; 2014 Sep; 37(9):835-42. PubMed ID: 24957168
[TBL] [Abstract][Full Text] [Related]
40. Influence of genetic variation in CYP3A4 and ABCB1 on dose decrease or switching during simvastatin and atorvastatin therapy.
Becker ML; Visser LE; van Schaik RH; Hofman A; Uitterlinden AG; Stricker BH
Pharmacoepidemiol Drug Saf; 2010 Jan; 19(1):75-81. PubMed ID: 19802823
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
